Opus Genetics, Inc. (IRD) stock
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.92−0.13 (-3.21%)
Close on Nov 18, 2026Market cap $326.13MP/E –Yield –
Opus Genetics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2009 it was -$100.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2009 | Dec 31, 2009 | -$100.00K | – |
See a number that looks wrong?